Literature DB >> 20197150

Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies.

Amy M West1, Christopher M Kramer.   

Abstract

Cardiovascular magnetic resonance provides the opportunity for a truly comprehensive evaluation of patients with a history of myocardial infarction, with regard to characterizing the extent of disease, effect on left ventricular function, and degree of viable myocardium. The use of contrast-enhanced cardiac magnetic resonance (CMR) imaging for first-pass perfusion and late gadolinium enhancement is a powerful technique for delineating areas of myocardial ischemia and infarction. Using a combination of T2-weighted and contrast-enhanced CMR images, information about the acuity of an infarct can be obtained. There is extensive published data using contrast-enhanced CMR to predict myocardial functional recovery with revascularization in patients with ischemic cardiomyopathies. In addition, CMR imaging in patients with cardiomyopathies can distinguish between ischemic and nonischemic etiologies, with the ability to further characterize the underlying pathology of nonischemic cardiomyopathies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197150      PMCID: PMC2861359          DOI: 10.1016/j.cpcardiol.2009.12.002

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  116 in total

1.  Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion.

Authors:  G Wisenberg; F S Prato; S E Carroll; K L Turner; T Marshall
Journal:  Am Heart J       Date:  1988-03       Impact factor: 4.749

2.  Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis.

Authors:  E R Holman; V G Buller; A de Roos; R J van der Geest; L H Baur; A van der Laarse; A V Bruschke; J H Reiber; E E van der Wall
Journal:  Circulation       Date:  1997-02-18       Impact factor: 29.690

3.  Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability.

Authors:  F M Baer; E Voth; K LaRosée; C A Schneider; P Theissen; H J Deutsch; H Schicha; E Erdmann; U Sechtem
Journal:  Am J Cardiol       Date:  1996-08-15       Impact factor: 2.778

4.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms.

Authors:  J A Lima; R M Judd; A Bazille; S P Schulman; E Atalar; E A Zerhouni
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

5.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

6.  Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.

Authors:  F M Baer; E Voth; C A Schneider; P Theissen; H Schicha; U Sechtem
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

7.  Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA--enhanced MR imaging.

Authors:  A de Roos; A C van Rossum; E van der Wall; S Postema; J Doornbos; N Matheijssen; P R van Dijkman; F C Visser; A E van Voorthuisen
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

8.  Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient.

Authors:  P B Bottini; A A Carr; L M Prisant; F W Flickinger; J D Allison; J S Gottdiener
Journal:  Am J Hypertens       Date:  1995-03       Impact factor: 2.689

9.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts.

Authors:  R M Judd; C H Lugo-Olivieri; M Arai; T Kondo; P Croisille; J A Lima; V Mohan; L C Becker; E A Zerhouni
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

10.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study.

Authors:  D Corrado; C Basso; G Thiene; W J McKenna; M J Davies; F Fontaliran; A Nava; F Silvestri; C Blomstrom-Lundqvist; E K Wlodarska; G Fontaine; F Camerini
Journal:  J Am Coll Cardiol       Date:  1997-11-15       Impact factor: 24.094

View more
  8 in total

1.  Pseudo-ischaemic ECG in a patient with amyotrophic lateral sclerosis surviving for a decade.

Authors:  Jian Zhang; Shi-Wei Yang; Zheng Wang; Guang-Ru Wei; Yu-Jie Zhou
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  Magnetic resonance imaging goes postmortem: noninvasive detection and assessment of myocardial infarction by postmortem MRI.

Authors:  Christian Jackowski; Marcel J B Warntjes; Johan Berge; Walter Bär; Anders Persson
Journal:  Eur Radiol       Date:  2010-07-20       Impact factor: 5.315

Review 3.  Is cardiac magnetic resonance imaging assessment of myocardial viability useful for predicting which patients with impaired ventricles might benefit from revascularization?

Authors:  Nicholas M Child; Rajiv Das
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-25

Review 4.  Emerging MRI methods in translational cardiovascular research.

Authors:  Moriel H Vandsburger; Frederick H Epstein
Journal:  J Cardiovasc Transl Res       Date:  2011-03-31       Impact factor: 4.132

5.  Manganese-Enhanced T1 Mapping in the Myocardium of Normal and Infarcted Hearts.

Authors:  N B Spath; D M L Lilburn; G A Gray; L M Le Page; G Papanastasiou; R J Lennen; R L Janiczek; M R Dweck; D E Newby; P C Yang; M A Jansen; S I Semple
Journal:  Contrast Media Mol Imaging       Date:  2018-10-25       Impact factor: 3.161

Review 6.  Cardiovascular magnetic resonance: contribution to the exploration of cardiomyopathies.

Authors:  Călin Schiau; Şerban Schiau; Sorin M Dudea; Simona Manole
Journal:  Med Pharm Rep       Date:  2019-10-25

7.  Evaluation of cardiomyopathy diagnosis in heart transplant recipients: comparison of echocardiographic and pathologic classification.

Authors:  Neda Behzadnia; Babak Sharif-Kashani; Zargham Hossein Ahmadi; Farah Naghashzadeh; Atosa Dorudinia; Alireza Jahangirifard; Hamoun Hamarz; Payam Abbasi
Journal:  Egypt Heart J       Date:  2021-03-25

8.  Cardiac Magnetic Resonance Imaging Might Complement Two-Dimensional Echocardiography in the Detection of a Reversible Nonischemic Cardiomyopathy.

Authors:  Raef Madanieh; Shawn Mathew; Pratik Shah; Satya K Vatti; Abed Madanieh; Constantine E Kosmas; Timothy J Vittorio
Journal:  Clin Med Insights Case Rep       Date:  2015-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.